Risks Associated with Use of Stimulant Medications in Patients with Obstructive Sleep Apnea and Cardiomyopathy: A Case-Control Study

Stimulant medications are indicated in patients with obstructive sleep apnea (OSA) who experience sleepiness despite optimal control of sleep-disordered breathing. The safety of stimulant medications in patients with OSA and co-morbid cardiomyopathy is unknown. We performed a case-control study to assess cardiovascular outcomes and mortality risk associated with stimulant use in this group of patients.

http://ift.tt/2kbLepa